Davita Inc vs Equinix Inc — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while Equinix Inc trades at $1,026.06 (market cap $99.77B). The key difference: Equinix Inc is far larger — about 8.8× Davita Inc's market cap, and Equinix Inc pays a 2.04% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and Equinix Inc for 110 Days on average.
| DVA | EQIX | |
|---|---|---|
Market Cap | $11.29B | $99.77B |
Volume | 582,204 | 480,425 |
Sector | Health | Real Estate |
52-Week High | $240.96 | $1.12K |
52-Week Low | $103.87 | $726.09 |
Typical Hold Time | 114 Days | 110 Days |
Enterprise Value | $24.01B | $120.90B |
Dividend Yield | — | 2.04% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.25, up 1.4% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows mixed technical signals with bearish moving averages but neutral oscillators, trading near resistance at $179. Fundamentally, revenue growth continues with 2025 revenue reaching $13.64B, though net margins compressed to 5.47% from 7.3% in 2024. Recent partnership expansion with Humana for value-based kidney care represents significant growth opportunity.
Outlook remains positive with analyst consensus target of $235.67 implying 31% upside, though elevated debt levels and regulatory risks require monitoring. The company benefits from demographic tailwinds in kidney care services and strong institutional support, including Berkshire Hathaway's 45% stake, providing stability amid market volatility.
Equinix (EQIX) trades at $1,026.06, down 0.55% on the day, amid a bearish technical signal. The stock shows strong fundamentals with revenue growth from $9.22B in 2025 to a projected $9.8B in 2026 and a net income margin of 15.63%. Recent earnings saw a mix of beats and misses, with Q2 2026 EPS of $4.83 exceeding expectations. Analyst sentiment remains overwhelmingly positive with a 75.47% buy rating and a consensus price target of $1,250.
The outlook for EQIX is supported by robust AI-driven data center demand and a $5B-$7B annual expansion plan, but risks include high valuation multiples (P/E of 65.07) and significant capital expenditures leading to negative cash flow. The stock presents a growth opportunity tied to digital infrastructure trends, though investors should weigh elevated debt levels and execution risks against long-term potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →